Skip to Content


Main Content

Impact of chronic graft-versus-host disease on non-relapse mortality and disease relapse in transplant recipients.

Study #: GV18-03

Study Status: Published


2021, TCT Meetings (Poster)

Chronic graft-versus-host disease, nonrelapse mortality, and disease relapse in older versus younger adults undergoing matched allogeneic peripheral blood hematopoietic cell transplantation: A Center for International Blood and Marrow Transplant Research Analysis.


Bhatt VR, Wang T, Chen K, Kitko CL, MacMillan ML, Pidala JA, Malki MM, Badawy SM, Beitinjaneh A, Ganguly S, Hamilton B, Hildebrandt GC, Lekakis LJ, Liu H, Maziarz RT, Modi D, Murthy HS, Preussler JM, Sharma A, Spellman SR, Arora M, Lee SJ.

Transplantation and Cellular Therapy. 2022, Jan 01: 28(1): 28(1):34-42. doi: 10.1016/j.jtct.2021.10.002. Epub 2021, Oct 09. PMCID:PMC8792177.


PMID: 34637965